|
1
|
Holt PR, Kozuch P and Mewar S: Colon
cancer and the elderly: From screening to treatment in management
of GI disease in the elderly. Best Pract Res Clin Gastroenterol.
23:889–907. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Radhakrishnan EK, Bava SV, Narayanan SS,
Nath LR, Thulasidasan AK, Soniya EV and Anto RJ: [6]-Gingerol
induces caspase-dependent apoptosis and prevents PMA-induced
proliferation in colon cancer cells by inhibiting MAPK/AP-1
signaling. PLoS One. 9:e1044012014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhu W and Xu B: MicroRNA-21 identified as
predictor of cancer outcome: A meta-analysis. PLoS One.
9:e1033732014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ribas J and Lupold SE: The transcriptional
regulation of miR-21, its multiple transcripts, and their
implication in prostate cancer. Cell Cycle. 9:923–929. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Young MR, Santhanam AN, Yoshikawa N and
Colburn NH: Have tumor suppressor PDCD4 and its counteragent
oncogenic miR-21 gone rogue? Mol Interv. 10:76–79. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang J, Du Y, Liu X, Cho WC and Yang Y:
MicroRNAs as regulator of signaling networks in metastatic colon
cancer. Biomed Res Int. 2015:8236202015.PubMed/NCBI
|
|
7
|
Hollis M, Nair K, Vyas A, Chaturvedi LS,
Gambhir S and Vyas D: MicroRNAs potential utility in colon cancer:
Early detection, prognosis, and chemosensitivity. World J
Gastroenterol. 21:8284–8292. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Melo SA and Esteller M: Dysregulation of
microRNAs in cancer: Playing with fire. FEBS Lett. 585:2087–2099.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Qiu X, Dong S, Qiao F, Lu S, Song Y, Lao
Y, Li Y, Zeng T, Hu J, Zhang L, et al: HBx-mediated miR-21
upregulation represses tumor-suppressor function of PDCD4 in
hepatocellular carcinoma. Oncogene. 32:3296–3305. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mercado-Pimentel ME, Onyeagucha BC, Li Q,
Pimentel AC, Jandova J and Nelson MA: The S100P/RAGE signaling
pathway regulates expression of microRNA-21 in colon cancer cells.
FEBS Lett. 589:2388–2393. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shi G, Shao J, Wang T, Wu D and Wang C:
Mechanism of berberine-mediated fluconazole-susceptibility
enhancement in clinical fluconazole-resistant Candida tropicalis
isolates. Biomed Pharmacother. 93:709–712. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Daniel B, Konrad B, Toplak M, Lahham M,
Messenlehner J, Winkler A and Macheroux P: The family of berberine
bridge enzyme-like enzymes: A treasure-trove of oxidative
reactions. Arch Biochem Biophys. 632:88–103. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li M, Zhang M, Zhang ZL, Liu N, Han XY,
Liu QC, Deng WJ and Liao CX: Induction of apoptosis by berberine in
hepatocellular carcinoma HepG2 cells via downregulation of NF-κB.
Oncol Res. 25:233–239. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li X, Zhang A, Sun H, Liu Z, Zhang T, Qiu
S, Liu L and Wang X: Metabolic characterization and pathway
analysis of berberine protects against prostate cancer. Oncotarget.
8:65022–65041. 2017.PubMed/NCBI
|
|
15
|
Zhu Y, Ma N, Li HX, Tian L, Ba YF and Hao
B: Berberine induces apoptosis and DNA damage in MG63 human
osteosarcoma cells. Mol Med Rep. 10:1734–1738. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
He SY, Jiang RF, Jiang J, Xiang YS and
Wang L: Investigation of methylation and protein expression of the
Runx3 gene in colon carcinogenesis. Biomed Rep. 3:687–690. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lee LD, Mafura B, Lauscher JC, Seeliger H,
Kreis ME and Gröne J: Antiproliferative and apoptotic effects of
telmisartan in human colon cancer cells. Oncol Lett. 8:2681–2686.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li DX, Zhang J, Zhang Y, Zhao PW and Yang
LM: Inhibitory effect of berberine on human skin squamous cell
carcinoma A431 cells. Genet Mol Res. 14:10553–10568. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen Q, Qin R, Fang Y and Li H: Berberine
sensitizes human ovarian cancer cells to cisplatin through
miR-93/PTEN/Akt signaling pathway. Cell Physiol Biochem.
36:956–965. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu X, Ji Q, Ye N, Sui H, Zhou L, Zhu H,
Fan Z, Cai J and Li Q: Berberine inhibits invasion and metastasis
of colorectal cancer cells via COX-2/PGE2 mediated JAK2/STAT3
signaling pathway. PLoS One. 10:e01234782015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Reid G: MicroRNAs in mesothelioma: From
tumour suppressors and biomarkers to therapeutic targets. J Thorac
Dis. 7:1031–1040. 2015.PubMed/NCBI
|
|
23
|
Pink RC, Samuel P, Massa D, Caley DP,
Brooks SA and Carter DR: The passenger strand, miR-21-3p, plays a
role in mediating cisplatin resistance in ovarian cancer cells.
Gynecol Oncol. 137:143–151. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang W, Li J, Zhu W, Gao C, Jiang R, Li W,
Hu Q and Zhang B: MicroRNA-21 and the clinical outcomes of various
carcinomas: A systematic review and meta-analysis. BMC Cancer.
14:8192014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Xu G, Zhang Y, Wei J, Jia W, Ge Z, Zhang Z
and Liu X: MicroRNA-21 promotes hepatocellular carcinoma HepG2 cell
proliferation through repression of mitogen-activated protein
kinase-kinase 3. BMC Cancer. 13:4692013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
He C, Dong X, Zhai B, Jiang X, Dong D, Li
B, Jiang H, Xu S and Sun X: MiR-21 mediates sorafenib resistance of
hepatocellular carcinoma cells by inhibiting autophagy via the
PTEN/Akt pathway. Oncotarget. 6:28867–28881. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hu HY, Li KP, Wang XJ, Liu Y, Lu ZG, Dong
RH, Guo HB and Zhang MX: Set9, NF-κB, and microRNA-21 mediate
berberine-induced apoptosis of human multiple myeloma cells. Acta
Pharmacol Sin. 34:157–166. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lo AK, Yuen PW, Liu Y, Wang XH, Cheung AL,
Wong YC and Tsao SW: Downregulation of hemidesmosomal proteins in
nasopharyngeal carcinoma cells. Cancer Lett. 163:117–123. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ferraro A, Kontos CK, Boni T, Bantounas I,
Siakouli D, Kosmidou V, Vlassi M, Spyridakis Y, Tsipras I, Zografos
G and Pintzas A: Epigenetic regulation of miR-21 in colorectal
cancer: ITGβ4 as a novel miR-21 target and a three-gene network
(miR-21-ITGβ4-PDCD4) as predictor of metastatic tumor potential.
Epigenetics. 9:129–141. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang Y, Gao X, Wei F, Zhang X, Yu J, Zhao
H, Sun Q, Yan F, Yan C, Li H and Ren X: Diagnostic and prognostic
value of circulating miR-21 for cancer: A systematic review and
meta-analysis. Gene. 533:389–397. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu S, Fang Y, Shen H, Xu W and Li H:
Berberine sensitizes ovarian cancer cells to cisplatin through
miR-21/PDCD4 axis. Acta Biochim Biophys Sin (Shanghai). 45:756–762.
2013. View Article : Google Scholar : PubMed/NCBI
|
